Skip to main content

A genomic signature of chemotherapeutic multidrug resistance provides a rational approach to identify patients for targeted therapy in advanced solid tumors

Publication ,  Conference
Anguiano, A; Mori, S; Chang, J; Vlahovic, V; Kelley, MJ; Ginsburg, G; Dressman, H; Nevins, JR; Potti, A
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 20, 2007

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 20, 2007

Volume

25

Issue

18

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Anguiano, A., Mori, S., Chang, J., Vlahovic, V., Kelley, M. J., Ginsburg, G., … Potti, A. (2007). A genomic signature of chemotherapeutic multidrug resistance provides a rational approach to identify patients for targeted therapy in advanced solid tumors. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 25). AMER SOC CLINICAL ONCOLOGY.
Anguiano, A., S. Mori, J. Chang, V. Vlahovic, M. J. Kelley, G. Ginsburg, H. Dressman, J. R. Nevins, and A. Potti. “A genomic signature of chemotherapeutic multidrug resistance provides a rational approach to identify patients for targeted therapy in advanced solid tumors.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.
Anguiano A, Mori S, Chang J, Vlahovic V, Kelley MJ, Ginsburg G, et al. A genomic signature of chemotherapeutic multidrug resistance provides a rational approach to identify patients for targeted therapy in advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.
Anguiano, A., et al. “A genomic signature of chemotherapeutic multidrug resistance provides a rational approach to identify patients for targeted therapy in advanced solid tumors.” JOURNAL OF CLINICAL ONCOLOGY, vol. 25, no. 18, AMER SOC CLINICAL ONCOLOGY, 2007.
Anguiano A, Mori S, Chang J, Vlahovic V, Kelley MJ, Ginsburg G, Dressman H, Nevins JR, Potti A. A genomic signature of chemotherapeutic multidrug resistance provides a rational approach to identify patients for targeted therapy in advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 20, 2007

Volume

25

Issue

18

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences